KVUE
Kenvue Inc.
NYSE · Consumer Defensive · Household & Personal Products · US
$18.74
−1.11%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
15.5x
EV/EBITDA
13.7x
Market Cap
$36.00B
MomentumView details →
1D Return
−1.11%
YTD Return
+9.83%
RSI (14)
47.3
ValuationView details →
P/E (Fwd)
15.5x
EV/EBITDA
13.7x
Market Cap
$36.00B
RSI (14)
47.3
MomentumView details →
1D Return
−1.11%
YTD Return
+9.83%
SummaryUpdated Jun 1, 2026
Kenvue Inc. (NYSE:KVUE) is a consumer health company that emerged as an independent entity in May 2023 following its spin-off from Johnson & Johnson. Founded in 2022 and headquartered in Skillman, New Jersey, Kenvue operates as one of the world's largest pure-play consumer health companies, managing a portfolio of trusted household brands that have been part of families' daily routines for decades. The company went public through an initial public offering in May 2023, marking its transition from being a subsidiary of J&J to a standalone publicly traded corporation focused exclusively on consumer health products.
Similar companies
Latest newsMore news →
The Australian Competition and Consumer Commission approved Kimberly-Clark Corporation's acquisition of Kenvue Inc., conditional on the divestiture of Kenvue's Carefree and Stayfree brands in Australia.3d agoKimberly-Clark filed with the European antitrust regulator for review of its deal involving Kenvue.9d agoBBB National Programs' National Advertising Division ruled on a challenge by Kenvue Inc., finding that Hims & Hers Health, Inc. had support for its comparative efficacy claim but recommending modification or discontinuance of other advertising claims.11d ago